Zur Hauptnavigation wechseln Zur Suche wechseln Zum Hauptinhalt wechseln

Age and case mix-standardised survival for all cancer patients in Europe 1999-2007: Results of EUROCARE-5, a population-based study

  • GRELL EUROCARE-5 Working Group
  • Analytical Epidemiology and Health Impact Unit
  • IRCCS Fondazione Don Carlo Gnocchi - Milano
  • Epidemiology Unit and Girona Cancer Registry
  • Catalan Institute of Oncology (ICO)
  • Netherlands Comprehensive Cancer Organisation
  • Department of Epidemiology and Biostatistics and Amsterdam Public Health Research Institute
  • MIRA Institute of Biomedical Technology and Technical Medicine
  • University of Twente
  • National Centre for Epidemiology Surveillance and Health Promotion (CNESPS)
  • National Institute for Health
  • Informatics service
  • Department of Health Sciences
  • University of Milan
  • PhD School in Applied Sociology and Methodology of Research
  • University of Milano–Bicocca
  • Department of Health Sciences (DISSAL)
  • Universität Genua
  • Austrian CR
  • Tyrol CR
  • Belgian CR
  • Bulgarian CR
  • Croatian CR
  • Czech National CR
  • Danish Cancer Society
  • Estonian CR
  • Tallinn University of Technology
  • Finnish CR
  • Bas Rhin CR
  • Basse Normandie Haematological malignancies CR
  • Calvados Digestive Tract Registry
  • Calvados
  • Côte d'Or Digestive Tract Registry
  • Côte d’Or Gynaecologic CR
  • Côte d’Or Haematological Malignancies CR
  • Doubs CR
  • Finistère Digestive Tract Registry
  • Gironde CNS CR
  • Gironde Haematological Malignancies CR
  • Hérault CR
  • Hospices Civils de Lyon
  • Isere Cancer Registry (Grenoble)
  • Loire-Atlantique CR
  • Manche CR
  • MSA Marne Ardennes Meuse
  • Somme CR
  • Tarn CR
  • Bavaria CR
  • Berlin CR

Abstract

Background Overall survival after cancer is frequently used when assessing a health care service's performance as a whole. It is mainly used by the public, politicians and the media, and is often dismissed by clinicians because of the heterogeneous mix of different cancers, risk factors and treatment modalities. Here we give survival details for all cancers combined in Europe, correlating it with economic variables to suggest reasons for differences. Methods We computed age and cancer site case-mix standardised relative survival for all cancers combined (ACRS) for 29 countries participating in the EUROCARE-5 project with data on more than 7.5 million cancer cases from 87 population-based cancer registries, using complete and period approach. Results Denmark, United Kingdom (UK) and Eastern European countries had lower survival than neighbouring countries. Five-year ACRS has been increasing throughout Europe, and substantial increases, between 1999-2001 and 2005-2007, have been achieved in countries where survival was lower in the past. Five-year ACRS for men and women are positively correlated with macro-economic variables like the Gross Domestic Product (GDP) and Total National Expenditure on Health (TNEH) (R 2 about 70%). Countries with recent larger increases in GDP and TNEH had greater increases in cancer survival. Conclusions ACRS serves to compare all cancer survival in Europe taking account of the geographical variability in case-mixes. The EUROCARE-5 data on ACRS confirm previous EUROCARE findings. Survival appears to correlate with macro-economic determinants, particularly with investments in the health care system.

OriginalspracheEnglisch
ZeitschriftEuropean Journal of Cancer
Jahrgang51
Ausgabenummer15
Seiten (von - bis)2120-2129
Seitenumfang10
ISSN0959-8049
DOIs
PublikationsstatusVeröffentlicht - 01.10.2015

Fördermittel

The study was funded by the Compagnia di San Paolo , Fondazione Cariplo Italy , Italian Ministry of Health (Ricerca Finalizzata 2009, RF-2009-1529710) and the European Commission (European Action Against Cancer, EPAAC, Joint Action No. 20102202). The funding sources had no role in study design, data collection, analysis or interpretation, the writing of the report or the decision to submit the article for publication.

UN SDGs

Dieser Output leistet einen Beitrag zu folgendem(n) Ziel(en) für nachhaltige Entwicklung

  1. SDG 3 – Gesundheit und Wohlergehen
    SDG 3 – Gesundheit und Wohlergehen

Fingerprint

Untersuchen Sie die Forschungsthemen von „Age and case mix-standardised survival for all cancer patients in Europe 1999-2007: Results of EUROCARE-5, a population-based study“. Zusammen bilden sie einen einzigartigen Fingerprint.

Dieses zitieren